Status:

COMPLETED

The Effect of Vitamin D Sublingual Spray on Vitamin D3 Levels in the Blood Compared to Other Forms of Vitamin D3

Lead Sponsor:

Pauls Stradins Clinical University Hospital

Conditions:

Vitamin D3 Deficiency

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The randomized comparative study was performed on 99 outpatients with below 30 ng/ml of vitamin D. Participants were randomized into three groups to receive vitamin D3 supplementation in three differe...

Detailed Description

This randomized comparative study was performed in Liepaja, Latvia, on 99 outpatients, with vitamin D levels below 30 ng/ml. Participants were randomized into three groups to receive vitamin D3 supple...

Eligibility Criteria

Inclusion

  • Vitamin D3 level in the blood below 30 ng/ml.

Exclusion

  • Celiac disease, Crohn's disease, ulcerative colitis, autoimmune gastritis.
  • Patients with mental health problems.
  • Vitamin D level ≥ 30 ng/ml.
  • Pregnant women.
  • Any other illness or condition that the researcher deemed may interfere with the results.
  • Patients who refuse the studies.

Key Trial Info

Start Date :

March 28 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 26 2021

Estimated Enrollment :

99 Patients enrolled

Trial Details

Trial ID

NCT06142136

Start Date

March 28 2021

End Date

April 26 2021

Last Update

November 21 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pauls Stradins Clinical Univeristy Hospital

Riga, Latvia, LV-1002